Short-Term Effects of Carbon Monoxide on Morbidity of Chronic Obstructive Pulmonary Disease With Comorbidities in Beijing

被引:1
作者
Li, Zhiwei [1 ,2 ]
Lu, Feng [3 ]
Liu, Mengmeng [1 ,2 ,4 ]
Guo, Moning [3 ]
Tao, Lixin [1 ,2 ]
Wang, Tianqi [3 ]
Liu, Mengyang [1 ,2 ,5 ]
Guo, Xiuhua [1 ,2 ,4 ,6 ]
Liu, Xiangtong [1 ,2 ]
机构
[1] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China
[2] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China
[3] Beijing Municipal Hlth Commiss Informat Ctr, Beijing, Peoples R China
[4] Capital Med Univ, Natl Inst Data Sci Hlth & Med, Beijing, Peoples R China
[5] Hebei Med Univ, Sch Publ Hlth, Shijiazhuang, Peoples R China
[6] Edith Cowan Univ, Ctr Precis Hlth, Sch Med & Hlth Sci, Joondalup, WA, Australia
来源
GEOHEALTH | 2023年 / 7卷 / 03期
关键词
CO; COPD; comorbidity; admission; ACUTE EXACERBATION; AIR-POLLUTION; PARTICULATE-MATTER; HOSPITALIZATIONS; QUALITY; TIME; COPD;
D O I
10.1029/2022GH000734
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The association between CO and chronic obstructive pulmonary disease (COPD) has been widely reported; however, the association among patients with type 2 diabetes mellitus (T2DM) or hypertension has remained largely unknown in China. Over-dispersed generalized additive model was adopted to quantity the associations between CO and COPD with T2DM or hypertension. Based on principal diagnosis, COPD cases were identified according to the International Classification of Diseases (J44), and a history of T2DM and hypertension was coded as E12 and I10-15, O10-15, P29, respectively. A total of 459,258 COPD cases were recorded from 2014 to 2019. Each interquartile range uptick in CO at lag 03 corresponded to 0.21% (95%CI: 0.08%-0.34%), 0.39% (95%CI: 0.13%-0.65%), 0.29% (95%CI: 0.13%-0.45%) and 0.27% (95%CI: 0.12%-0.43%) increment in admissions for COPD, COPD with T2DM, COPD with hypertension and COPD with both T2DM and hypertension, respectively. The effects of CO on COPD with T2DM (Z = 0.77, P = 0.444), COPD with hypertension (Z = 0.19, P = 0.234) and COPD with T2DM and hypertension (Z = 0.61, P = 0.543) were insignificantly higher than that on COPD. Stratification analysis showed that females were more vulnerable than males except for T2DM group (COPD: Z = 3.49, P Z = 0.176, P = 0.079; COPD with hypertension: Z = 2.48, P = 0.013; COPD with both T2DM and hypertension: Z = 2.44, P = 0.014); No statistically significant difference could be found between age groups (COPD: Z = 1.63, P = 0.104; COPD with T2DM: Z = 0.23, P = 0.821; COPD with hypertension: Z = 0.53, P = 0.595; COPD with both T2DM and hypertension: Z = 0.71, P = 0.476); Higher effects appeared in cold seasons than warm seasons on COPD (Z = 0.320, P < 0.001). This study demonstrated an increased risk of COPD with comorbidities related to CO exposure in Beijing. We further provided important information on lag patterns, susceptible subgroups, and sensitive seasons, as well as the characteristics of the exposure-response curves.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review
    Xiang, Yurong
    Luo, Xiaobin
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 567 - 578
  • [32] Chronic obstructive pulmonary disease and comorbidities through the eyes of the patient
    Boeckxstaens, Pauline
    Deregt, Marina
    Vandesype, Piet
    Willems, Sara
    Brusselle, Guy
    De Sutter, An
    [J]. CHRONIC RESPIRATORY DISEASE, 2012, 9 (03) : 183 - 191
  • [33] Does bronchiectasis affect chronic obstructive pulmonary disease comorbidities?
    Nowinski, Adam
    Korzybski, Damian
    Bednarek, Michal
    Goljan-Geremek, Anna
    Puscinska, Elzbieta
    Sliwinski, Pawel
    [J]. ADVANCES IN RESPIRATORY MEDICINE, 2019, 87 (06) : 214 - 220
  • [34] Impact of the spirometric definition on comorbidities in chronic obstructive pulmonary disease
    Meteran, Howraman
    Thomsen, Simon Francis
    Miller, Martin R.
    Hjelmborg, Jacob
    Sigsgaard, Torben
    Backer, Vibeke
    [J]. RESPIRATORY MEDICINE, 2021, 184
  • [35] Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
    Divo, Miguel
    Cote, Claudia
    de Torres, Juan P.
    Casanova, Ciro
    Marin, Jose M.
    Pinto-Plata, Victor
    Zulueta, Javier
    Cabrera, Carlos
    Zagaceta, Jorge
    Hunninghake, Gary
    Celli, Bartolome
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (02) : 155 - 161
  • [36] Comorbidities and mortality among patients with chronic obstructive pulmonary disease
    Skajaa, Nils
    Laugesen, Kristina
    Horvath-Puho, Erzsebet
    Sorensen, Henrik Toft
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [37] Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art
    Patel, Anant R. C.
    Hurst, John R.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (05) : 647 - 662
  • [38] Long-term effects of air pollution on hospital admissions and mortality for chronic obstructive pulmonary disease in Beijing, China
    Zhu, Rui-xia
    Chen, Jin
    [J]. CLINICAL RESPIRATORY JOURNAL, 2023, 17 (07) : 672 - 683
  • [39] A Multicity Analysis of the Short-Term Effects of Air Pollution on the Chronic Obstructive Pulmonary Disease Hospital Admissions in Shandong, China
    Liu, Yi
    Sun, Jingjie
    Gou, Yannong
    Sun, Xiubin
    Li, Xiujun
    Yuan, Zhongshang
    Kong, Lizhi
    Xue, Fuzhong
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (04)
  • [40] The Outcomes of Short Term Outpatient Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
    Gokoglu, Figen
    Bilgin, Gulden
    Okumus, Muyesser
    Vural, Arife
    Yorgancioglu, Zeynep Rezan
    Palulu, Nilgun
    [J]. TURKISH THORACIC JOURNAL, 2006, 7 (03) : 173 - 177